GFACX
Price
$70.27
Change
-$0.64 (-0.90%)
Updated
Nov 14 closing price
MRLSX
Price
$20.80
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

GFACX vs MRLSX

Header iconGFACX vs MRLSX Comparison
Open Charts GFACX vs MRLSXBanner chart's image
American Funds Growth Fund of Amer C
Price$70.27
Change-$0.64 (-0.90%)
VolumeN/A
CapitalizationN/A
AMG Renaissance Large Cap Growth I
Price$20.80
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
GFACX vs MRLSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. MRLSX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and MRLSX is a StrongSell.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 306B vs. MRLSX (145M). MRLSX pays higher dividends than GFACX: MRLSX (0.27) vs GFACX (0.00). GFACX was incepted earlier than MRLSX: GFACX (24 years) vs MRLSX (15 years). MRLSX is a more actively managed with annual turnover of: 35.00 vs. GFACX (31.00). GFACX has a lower initial minimum investment than MRLSX: GFACX (250) vs MRLSX (100000). GFACX annual gain was more profitable for investors over the last year : 27.83 vs. MRLSX (22.15). MRLSX return over 5 years is better than : 52.14 vs. GFACX (47.10).
GFACXMRLSXGFACX / MRLSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years15 years-
Gain YTD27.76423.515118%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets306B145M211,034%
Annual Yield % from dividends0.000.27-
Returns for 1 year27.8322.15126%
Returns for 3 years-6.177.01-88%
Returns for 5 years47.1052.1490%
Returns for 10 years57.9558.3699%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NABL11.020.01
+0.09%
N-able
ATI58.37-0.39
-0.66%
ATI
NGNE39.54-0.46
-1.15%
Neurogene
SXTC0.46-0.01
-2.11%
China SXT Pharmaceuticals
BMR2.73-0.13
-4.71%
Beamr Imaging Ltd